FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/13/2025
Back to search
Official data from USPTO
DOPPL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079347151Class
1, 5, 9, 10, 42, 44, 45
Filing
79347151
Registration
7553975
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
04/03/2026
Trademark type
Combined
Nice classes
1, 5, 9, 10, 42, 44, 45
Filing date
05/16/2022
Registration date
11/05/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/05/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
CH
Examiner
CHUNG, DIANA ALANA
Law office
O20
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized term "DOPPL" where in the letters "P" are interconnected.
Holders and representatives
Holders
DOPPL S.A
Sun bioscience SA
Representatives
Michael J. Kosma Sherman & Howard
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10Class 42Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical substances being preparations for preserving foodstuffs; chemical preparations for scientific use other than for medical or veterinary use; chemical products being preparations for scientific analyses in laboratories other than for medical or veterinary use; chemical reagents other than for medical or veterinary use; biological preparations for use in science and industry other than for medical or veterinary use; biological tissue cultures other than for medical or veterinary purposes; bacteriological preparations being biological preparations for use in science and industry and other than for medical or veterinary use; bacterial preparations being biological preparations for use in science and industry and other than for medical or veterinary use; bacteriological preparations being biological preparations for use in science and industry for acetification; vitamins for the food industry; vitamins for use in the manufacture of food supplements; vitamins for use in the manufacturing pharmaceutical products; vitamins for use in the manufacturing cosmetics; antioxidants used during manufacturing operations; antioxidants for use in the manufacture of cosmetics; antioxidants for use in the manufacture of food supplements; antioxidants for use in the manufacture of pharmaceutical products; enzyme preparations for industrial use; enzyme preparations for the food industry; enzymes for the food industry
Class 5
Pharmaceutical preparations for the prevention and treatment of cancerinflammatory diseaseimmune system diseasecardiovascular diseaseneurological and intestinal diseasegenetic disorders; pharmaceutical products being preparations for the prevention and treatment of cancerinflammatory diseaseimmune system diseasecardiovascular diseaseneurological and intestinal diseasegenetic disorders; chemical-pharmaceutical preparations for the prevention and treatment of cancerinflammatory diseaseimmune system diseasecardiovascular diseaseneurological and intestinal diseasegenetic disorders; chemical preparations for medical use for the prevention and treatment of cancerinflammatory diseaseimmune system diseasecardiovascular diseaseneurological and intestinal diseasegenetic disorders; chemical preparations for pharmaceutical use for the prevention and treatment of cancerinflammatory diseaseimmune system diseasecardiovascular diseaseneurological and intestinal diseasegenetic disorders; biological preparations for medical use for the prevention and treatment of cancerinflammatory diseaseimmune system diseasecardiovascular diseaseneurological and intestinal diseasegenetic disorders; biological preparations for veterinary use for the prevention and treatment of cancerinflammatory diseaseimmune system diseasecardiovascular diseaseneurological and intestinal diseasegenetic disorders; vitamin preparations; biological tissue cultures for medical use; biological tissue cultures for veterinary use; cultures of microorganisms for medical or veterinary use; preparations being cultures of microorganisms for medical and veterinary use; bacterial culture preparations for medical or veterinary use; bacteriological culture preparations for medical or veterinary use; diagnostic preparations in the nature of biomarking reagents for medical use; diagnostic preparations for medical use; diagnostic preparations for veterinary use; enzyme food supplements; enzyme preparations for medical use; enzyme preparations for veterinary use; enzymes for medical use; enzymes for veterinary use; immunostimulants; medicinal drinks; medicines for human use for the prevention and treatment of cancerinflammatory diseaseimmune system diseasecardiovascular diseaseneurological and intestinal diseasegenetic disordersremedies being medications for the prevention and treatment of cancerinflammatory diseaseimmune system diseasecardiovascular diseaseneurological and intestinal diseasegenetic disorders for human use; medicines for veterinary use for the prevention and treatment of cancerinflammatory diseaseimmune system diseasecardiovascular diseaseneurological and intestinal diseasegenetic disordersremedies being medicines for veterinary use for the prevention and treatment of cancerinflammatory diseaseimmune system diseasecardiovascular diseaseneurological and intestinal diseasegenetic disorders; nutraceutical preparations for therapeutic or medical use for the prevention and treatment of cancerinflammatory diseaseimmune system diseasecardiovascular diseaseneurological and intestinal diseasegenetic disorders; nutritive substances being nutritional supplements for microorganisms; nutritional supplements; opotherapy products being medicinal preparations for the prevention and treatment of cancerinflammatory diseaseimmune system diseasecardiovascular diseaseneurological and intestinal diseasegenetic disorders; protein food supplements; protein supplements for animals; stem cells for medical use; stem cells for veterinary use; preparations of trace elements for human and animal consumption being nutritional supplements
Class 9
Apparatus for fermentation for laboratory use; chemistry apparatus and instrumentsfermentation apparatus for laboratory use for producing bioactive compoundslaboratory robots with artificial intelligencelaboratory robots with automated analysis pipelinesresearch laboratory analyzers for measuringtesting and analyzing blood and other bodily fluidslockable petri dishes used in laboratory researchdiagnostic apparatus for the detection of pathogens for laboratory or research uselaboratory organ-on-chip manufacturing equipmentlaboratory 3D cell culture manufacturing equipment; downloadable computer software applications for calculations made for scientific analysis of chemical reactionsdownloadable computer software applications for scientific analysis of chemical and biological reactions and downloadable computer software applications for consent management; diagnostic apparatus not for medical use for detection of pathogens for use in laboratory or research use ; DNA chips; laboratory trays
Class 10
Medical apparatus and instruments for use in preventing and treating cancerinflammatory diseaseimmune system diseasecardiovascular diseaseneurological and intestinal diseasegenetic disorders; diagnostic apparatus for medical use for analysis and detection of cancerinflammatory diseaseimmune system diseasecardiovascular diseaseneurological and intestinal diseasegenetic disorders; cancerinflammatory diseaseimmune system diseasecardiovascular diseaseneurological and intestinal disease; genetic disorders testing apparatus for medical use; blood testing apparatus; body composition monitors; body fat monitors; physical rehabilitation apparatus for medical use; surgical implants comprised of artificial materials; DNA and RNA testing apparatus for medical use; apparatus for the regeneration of stem cells for medical use
Class 42
Scientific research; scientific research services for medical purposes; scientific laboratory services; Software as a Service (SaaS) services featuring software for calculations made for scientific analysis of chemical reactions; computer Platform as a Service (PaaS) services featuring software for calculations made for scientific analysis of chemical reactions; medical and scientific research in bacteriology; biological research; chemical analysis; chemical research; chemistry serviceschemical analysis and research for others; medical and scientific researchconducting clinical trials for others
Class 44
Medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes being the treatment of persons and animals; medical screening; human tissue bank services; telemedicine services
Class 45
Intellectual property licensing
Publications
History of USPTO decisions and trademark events.
34 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
04/04/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
04/04/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/05/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/05/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
11/05/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/20/2024
PUBO
PUBLISHED FOR OPPOSITION
08/20/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/31/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/18/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/17/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/17/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
07/17/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
02/05/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/22/2024
GNFR
FINAL REFUSAL E-MAILED
01/22/2024
CNFR
FINAL REFUSAL WRITTEN
01/22/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/17/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/17/2024
DOCK
ASSIGNED TO EXAMINER
12/06/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/01/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/02/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/02/2023
CHLD
CHANGE OF OWNER RECEIVED FROM IB
10/27/2023
RFNT
REFUSAL PROCESSED BY IB
05/24/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/02/2023
RFRR
REFUSAL PROCESSED BY MPU
05/02/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/13/2023
CNRT
NON-FINAL ACTION WRITTEN
03/12/2023
DOCK
ASSIGNED TO EXAMINER
03/06/2023
MAFR
APPLICATION FILING RECEIPT MAILED
08/16/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/12/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/11/2022
Continuous trademark protection
Get notified about every new filing that threatens DOPPL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.